【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Company Snapshot 7
Key Information 7
Company Overview 7
Birchcliff Energy Ltd., Valuation and Financial Data 8
Birchcliff Energy Ltd., Share Price Performance 8
Share Price Performance, Q1, 2012-Q1, 2013 8
Birchcliff Energy Ltd., Key Valuation Metrics 9
Key Valuation Metrics, Q1, 2012-Q1, 2013 9
Birchcliff Energy Ltd., Quarterly Results of Oil & Gas Operations Per boe Produced 10
Results of Oil & Gas Operations Per boe Produced, Q1, 2012-Q1, 2013 10
Results of Oil & Gas Operations Per boe Growth Rates, Q1, 2012-Q1, 2013 11
Birchcliff Energy Ltd., Quarterly E&P Costs Trends 12
Upstream Capital Expenditure, Q1, 2012-Q1, 2013 12
Birchcliff Energy Ltd., Quarterly Production Trends 13
Birchcliff Energy Ltd., Total Oil and Gas Production 13
Total Crude Oil and Natural Gas Production Trend, Q1, 2012-Q1, 2013 13
Total Crude Oil & Natural Gas Production, By Country/Region, Q1, 2012-Q1, 2013 14
Birchcliff Energy Ltd., Crude Oil Production 15
Total Crude Oil Production Trend, Q1, 2012-Q1, 2013 15
Crude Oil Production, By Country/Region, Q1, 2012-Q1, 2013 16
Birchcliff Energy Ltd., Natural Gas Production 17
Total Natural Gas Production Trend, Q1, 2012-Q1, 2013 17
Natural Gas Production, By Country/Region, Q1, 2012-Q1, 2013 18
Birchcliff Energy Ltd., Valuation and Financial Data, 2008-2012 19
Birchcliff Energy Ltd., Share Price Performance, 2008-2012 19
Share Price Performance, 2008-2012 19
Key Valuation Metrics, 2008-2012 20
Birchcliff Energy Ltd., Production and Reserves Trends 21
Total Oil and Gas, Reserves and Production 21
Total Crude Oil and Natural Gas Production and Reserves Trend, 2008-2012 21
Total Crude Oil & Natural Gas Production and Reserves By Country/Region, 2008-2012 22
Total Crude Oil and Natural Gas Reserve Changes, 2008-2012 24
Crude Oil/Liquids Production and Reserve 25
Crude Oil/Liquids Production and Reserve Trend, 2008-2012 25
Crude Oil Production and Reserves By Country/Region, 2008-2012 26
Crude Oil/Liquids Reserve Changes, 2008-2012 28
Natural Gas Production and Reserve 29
Natural Gas Production and Reserve Trend, 2008-2012 29
Natural Gas Production and Reserves, By Country/Region, 2008-2012 30
Natural Gas Reserve Changes, 2008-2012 32
Total Crude Oil and Natural Gas Reserves Life Index 33
Total Crude Oil and Natural Gas Reserves Life Index, 2008-2012 33
Total Crude Oil and Natural Gas Reserves Life Index, By Country/Region, 2008-2012 34
Birchcliff Energy Ltd., E&P Costs Trends 36
Allocation of the Upstream Capital Expenditure 36
Upstream Capital Expenditure, 2008-2012 36
Acquisition Costs By Country/Region, 2008-2012 37
Exploration and Development Costs, By Country/Region, 2008-2012 39
Oil and Gas Cost Per boe, $/boe 41
Oil and Gas Cost Per boe, $/boe, 2008-2012 41
Oil and Gas Cost Per boe, $/boe, By Country/Region, 2008-2012 43
Birchcliff Energy Ltd., Reserve Replacement Ratio 45
Oil and Gas Production Replacement Ratio 45
Oil and Gas Production Replacement Ratio, 2008-2012 45
Oil and Gas Production Replacement Ratio, By Country/Region, 2008-2012 47
Birchcliff Energy Ltd., Results of Oil & Gas Operations Trend 51
Oil and Gas Revenue and Expenses 51
Oil and Gas Revenue and Expenses, 2008-2012 51
Oil and Gas Revenue and Expenses, By Country/Region, 2008-2012 52
Oil and Gas Revenue and Expenses, Per boe 56
Oil and Gas Revenue and Expenses, By boe, 2008-2012 56
Oil and Gas Revenue and Expenses Per boe, By Country/Region, 2008-2012 57
Oil and Gas Performance Metrics 61
Birchcliff Energy Ltd., Land Holdings and Well Data 62
Developed and Undeveloped Acreage 62
Gross and Net Developed and Undeveloped Acreage, 2008-2012 62
Gross and Net Developed and Undeveloped Acreage, By Country/Region, 2008-2012 63
Well Statistics 65
Producible Oil and Gas Well, 2008-2012 65
Producible Oil and Gas Well, By Country/Region, 2008-2012 66
Exploration and Development Wells Drilled, 2008-2012 70
Exploration and Development Wells Drilled, By Country/Region, 2008-2012 71
Recent Developments 72
Birchcliff Energy Ltd. – Recent Developments 72
Mar 13, 2013: Birchcliff Energy Provides Operations Update 72
Feb 13, 2013: Birchcliff Energy Reports Revenue Of C$257.2 MM In 2012 72
Nov 14, 2012: Birchcliff Energy Reports Revenue Of CAD58.6m In Q3 2012 73
Oct 16, 2012: Birchcliff Energy Announces Record Production And Phase III Expansion Of PCS Gas Plant Complete 74
Aug 14, 2012: Birchcliff Energy Reports Revenue Of CAD57.7m In Q2 2012 75
Jun 26, 2012: Birchcliff Energy Increases Bank Credit Facilities To $540m 76
May 15, 2012: Birchcliff Energy Reports Revenue Of CAD62.8m In Q1 2012 76
Mar 14, 2012: Birchcliff Energy Reports Revenue Of CAD264.6m In 2011 77
Mar 14, 2012: Birchcliff Energy Provides 2011 Production And Operations Update 77
Feb 23, 2012: Birchcliff Energy Provides Production Update 79
Appendix 80
Methodology 80
Coverage 80
Secondary Research 80
Primary Research 80
Data Information Sources 81
Company Source 81
SEC/Other Regulatory Filings 81
Other Sources 81
Expert Panel Validation 81
Data Definition 81
Oil and Gas Reserves 81
Units of Measure 82
About GlobalData 82
Disclosure 82
Disclaimer 82
Note: The report is based on the information disclosed by the company in their annual report and regulatory filings. Information that is not disclosed by the company may not be available in the report.
【レポート販売概要】
■ タイトル：Birchcliff Energy Ltd.：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013■ 英文：Birchcliff Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013
■ 発行日：2013年6月27日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161159
■ 調査対象地域：グローバル
- 腎盂腎炎(Pyelonephritis)の治療薬パイプライン動向（2015年上半期版）Pyelonephritis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Pyelonephritis - Pipeline Review, H1 2015’, provides an overview of the Pyelonephritis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pyelonephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ( …
- エアボーンテレメトリー（遠隔測定法）の世界市場予測（～2021）：ワイヤード、ワイヤレス、レシーバー、トランスミッタ、アンテナ、センサーThe airborne telemetry market is projected to grow from USD 7.08 Billion in 2016 to USD 8.52 Billion by 2021, at a CAGR of 3.78% during the forecast period. Various factors, such as growing use of software defined radio technology, emergence of modern electronic warfare and network-centric warfare systems, and the increased use of wireless and cloud computing technologies are expected to fuel the …
- ジメチルエーテル（DME）の世界市場動向及び予測Dimethyl ether (DME) is an non-poisonous gas, which is liquefiable at a pressure of around 6 bars for storage purpose. It is used as a solvent in the petrochemical industry. The raw materials used in DME manufacturing process are coal, natural gas, bio-based feedstock and methanol. DME consist no sulfur content which gives an advantage of clean burning properties. It has various applications such …
- 木材用接着剤及びバインダーの世界市場2015-2019About Wood Adhesives and Binders Wood adhesives and binders are used to bind together wood surfaces to create panels. They have high bond strength, durability, and temperature and chemical resistance, which provides customers with cost-effective solutions. They are used for various industrial and consumer applications such as in flooring, furniture and subcomponents, windows and doors, and cabinet …
- 皮下注射針の世界市場2019-2023About this market Introduction of user-friendly features in hypodermic needles to drive growth in the market. Advances in technology have paved the way for the development of hypodermic needles with user-friendly features such as shorter needles. fine gauge needles for lesser pain. and the absence of recapping to reduce infection exposure. The user-friendly features in hypodermic needles assist pa …
- 世界の経皮的冠動脈形成術用薬剤溶出性バルーンカテーテル市場：医療機器パイプライン分析2016Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016" provides an overview of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloo …
- 世界の公共安全LTE市場：インフラストラクチャ別（E-UTRAN、EPC）、サービス別（コンサルティング、統合）、展開モデル別（プライベート、ハイブリッド）、用途別（法執行、消防サービス）、地域別“The PS-LTE market is projected to grow at a CAGR of 20.2% from 2019 to 2024.” The PS-LTE market is projected to grow from USD 4.7 billion in 2019 to USD 11.7 billion by 2024; it is expected to grow at a CAGR of 20.2% from 2019 to 2024. The adoption of LTE technology to eliminate the existing interconnectivity issues between different networks, increase in demand for unmanned vehicles globally, an …
- 脂肪性肝疾患(Fatty Liver Disease)：世界の治験レビュー（2015年上半期版）Fatty Liver Disease Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Fatty Liver Disease Global Clinical Trials Review, H1, 2015" provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recru …
- 医薬品有効成分（API）の世界市場2017-2021About Active Pharmaceutical IngredientsA drug is generally composed of APIs and excipients. Active Pharmaceutical Ingredients are chemical compounds or a combination of compounds that are used primarily to have the desired effect on biological systems. Excipients are inactive ingredients in a drug that are used to disperse APIs. APIs may be synthesized either through chemical or biotechnological m …
- Savella (大うつ病性障害)：医薬品市場予測及び分析（～2023）Savella (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for …
- 心臓バイオマーカー検査の世界市場：種類別（心筋マッスルクレアチンキナーゼ、トロポニン、ミオグロビン、脳性ナトリウム利尿ペプチド、虚血修飾アルブミンなど）、用途別（心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症など）、検査場所別（ポイントオブケア検査、臨床検査）The global cardiac biomarker market generated $7,638 million in 2018, and is projected to reach $18,232 million by 2026, growing at a CAGR of 11.4%. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state as well as for diagnostic and prognostic purposes associated with heart. The prevention of cardiac diseases by monitoring heart conditions via cardiac bio …
- 栗の世界市場：種類別、地域別Global Chestnuts Market: About this market Technavio’s chestnuts market analysis considers sales from Asiatic chestnut species, European chestnut species, and American chestnut species. Our study also finds the sales of chestnuts in APAC, Europe, MEA, North America, and South America. In 2019, the Asiatic chestnut species segment had a significant market share, and this trend is expected to contin …
- ゴム製タイヤ＆チューブのパキスタン市場：経路別（OEM、アフターマーケット）、構成要素別（タイヤ、チューブ）、デザイン別（ラジアル、バイアス）、車両種類別（乗用車、商用車、二輪車、三輪車、農業用トラクター、OTR/TBR）A tyre is a component fitted around the rim of a wheel to transfer the load of a vehicle from the axle to the ground. Rubber tyre consists of tread, jointless cap piles, beads, and other materials, which include synthetic rubber, carbon black, and fabric. The major function of the tyre is to protect the wheel rim and offer tractive force between the road surface and the vehicle. Since, it is manuf …
- OAO Novatek：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012OAO Novatek Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary OAO Novatek Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational …
- Zaltrap：大腸癌治療薬市場分析Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on h …
